Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical device
|
| gptkbp:CEO |
gptkb:Jason_Hannon
|
| gptkbp:countryOfOperation |
gptkb:Germany
gptkb:Ireland gptkb:United_States |
| gptkbp:focusesOn |
chronic low back pain
|
| gptkbp:foundedYear |
2008
|
| gptkbp:headquartersLocation |
gptkb:Dublin,_Ireland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mainstay Medical
|
| gptkbp:industry |
medical devices
|
| gptkbp:listedOn |
gptkb:Euronext_Growth_Dublin
gptkb:Euronext_Paris |
| gptkbp:product |
gptkb:ReActiv8
|
| gptkbp:productType |
implantable neurostimulation system
|
| gptkbp:regulates |
gptkb:CE_Mark
FDA approval |
| gptkbp:stockSymbol |
gptkb:MSTY
|
| gptkbp:targetMarket |
patients with chronic low back pain
|
| gptkbp:website |
https://www.mainstaymedical.com/
|
| gptkbp:bfsParent |
gptkb:Sofinnova_Investments
|
| gptkbp:bfsLayer |
6
|